CREB-binding protein in androgen receptor-mediated signaling
Open accessAbstract
CREB-binding protein (CBP) is a transcriptional coregulator that interacts with different DNA binding proteins and components of the general transcription machinery. CBP enhanced androgen receptor (AR)-dependent transcription under transient transfection conditions in CV-1 cells. The ligand binding domain (LBD) and residues 38–296 of the N-terminal region of AR are not required because the activity of a receptor mutant devoid of these domains was augmented by coexpressed CBP. There is physical interaction between AR and CBP in vivo , as judged by coimmunoprecipitation experiments from cell extracts. Consistent with the role of CBP as a coactivator for AR, the 12S E1A adenoviral protein that inactivates CBP function strongly inhibited AR-dependent transactivation. Exogenous CBP was also capable of overcoming the inhibitory effect of AR on AP-1 activity and diminished the mutual transcriptional repression between AR and NF-κB (RelA). Collectively, these data imply that transcriptional interference between AR and AP-1 or NF-κB is mediated, at least in part, through competition for intracellular CBP and that this coactivator serves as an integrator between androgen-mediated and other signaling pathways.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Animal steroid hormones exert their actions via binding to their intracellular nuclear receptors.
“Animal steroid hormones are known exert their actions via binding to their intracellular nuclear receptors [7], for example, estrogen binds to its nuclear estrogen receptors ERα and ERβ [8], androgens bind to androgen receptors (AR) [9], and glucocorticoids bind to glucocorticoid receptors [10].”
From G protein-coupled receptors function as cell membrane receptors for the steroid hormone 20-hydroxyecdysone (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,442 · see citing works
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952 · see citing works
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S., Tsai, S., Tsai, M.-J., & O'Malley, B. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,507 · see citing works
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150 · see citing works
Phosphorylated CREB binds specifically to the nuclear protein CBP
Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., & Goodman, R. H. (1993) · Nature · doi:10.1038/365855a0 · Cited by 2,052 · see citing works
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X., Ogryzko, V. V., Nishikawa, J., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,473 · see citing works
Nuclear protein CBP is a coactivator for the transcription factor CREB
Kwok, R. P. S., Lundblad, J. R., Chrivia, J. C., Richards, J. P., Bächinger, H. P., Brennan, R. G., Roberts, S. G. E., Green, M. R., & Goodman, R. H. (1994) · Nature · doi:10.1038/370223a0 · Cited by 1,443 · see citing works
Transcriptional activation: A complex puzzle with few easy pieces
Tjian, R., & Maniatis, T. (1994) · Cell · doi:10.1016/0092-8674(94)90227-5 · Cited by 1,108 · see citing works
Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P., & Gronemeyer, H. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00736.x · Cited by 1,080 · see citing works
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064 · see citing works
Nuclear receptor coactivators and corepressors
Horwitz, K. B., Jackson, T. A., Bain, D. L., Richer, J. K., Takimoto, G. S., & Tung, L. W. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.10.9121485 · Cited by 943 · see citing works
Role of CBP/P300 in nuclear receptor signalling
Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., & Evans, R. M. (1996) · Nature · doi:10.1038/383099a0 · Cited by 930 · see citing works
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 811 · see citing works
The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B.
Schmitz, M. L., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04950.x · Cited by 796 · see citing works
Steroid Hormone Receptors: Interaction with Deoxyribonucleic Acid and Transcription Factors*
Truss, M., & Beato, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-459 · Cited by 739 · see citing works
Activation of cAMP and mitogen responsive genes relies on a common nuclear factor
Arias, J., Alberts, A. S., Brindle, P. K., Claret, F. X., Smeal, T., Karin, M., Feramisco, J. R., & Montminy, M. (1994) · Nature · doi:10.1038/370226a0 · Cited by 726 · see citing works
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D., & Nabel, G. J. (1997) · Science · doi:10.1126/science.275.5299.523 · Cited by 722 · see citing works
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 697 · see citing works
The nuclear hormone receptor coactivator SRC-1 is a specific target of p300.
Yao, T., Ku, G., Zhou, N., Scully, R., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10626 · Cited by 453 · see citing works
Sakai, D. D., Helms, S. R., Carlstedt‐Duke, J., Gustafsson, J.-Α., ROTTMAN, F. M., & Yamamoto, K. R. (1988) · Genes & Development · doi:10.1101/gad.2.9.1144 · Cited by 448 · see citing works
Nuclear Receptor/AP-1 Interaction*
Pfahl, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-651 · Cited by 445 · see citing works
Interaction of thyroid-hormone receptor with a conserved transcriptional mediator
Lee, J. W., Ryan, F., Swaffield, J. C., Johnston, S. A., & Moore, D. D. (1995) · Nature · doi:10.1038/374091a0 · Cited by 425 · see citing works
Smith, C. L., Oñate, S. A., Tsai, M., & O’Malley, B. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8884 · Cited by 412 · see citing works
p300 is a component of an estrogen receptor coactivator complex.
Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B. T., Kurokawa, R., & Brown, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11540 · Cited by 396 · see citing works
Interaction of proteins with transcriptionally active estrogen receptors.
Cavaillès, V., Dauvois, S., Danielian, P. S., & Parker, M. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10009 · Cited by 373 · see citing works
Ikonen, T., Palvimo, J. J., & Jänne, O. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29821 · Cited by 365 · see citing works
Self-citationCBP as a transcriptional coactivator of c-Myb.Preprint
Dai, P., Akimaru, H., Tanaka, Y., Hou, D., Yasukawa, T., Kanei‐Ishii, C., Takahashi, T., & Ishii, S. (1996) · Genes & Development · doi:10.1101/gad.10.5.528 · Cited by 344 · see citing works
CBP‐induced stimulation of c‐Fos activity is abrogated by E1A.
Bannister, A. J., & Kouzarides, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00157.x · Cited by 336 · see citing works
Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II).
Ing, N. H., Beekman, J. M., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37087-5 · Cited by 336 · see citing works
Baniahmad, A., Ha, I., Reinberg, D., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8832 · Cited by 330 · see citing works
Novel glucocorticoid receptor complex with DNA element of the hormone‐repressed POMC gene.
Drouin, J., Sun, Y., Chamberland, M., Gauthier, Y., Léan, A. D., Nemer, M. J., & Schmidt, T. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05640.x · Cited by 319 · see citing works
(1995) · PubMed · Cited by 312 · see citing works
Molecular mechanisms of anti‐inflammatory action of glucocorticoids
Cato, A. C. B., & Wade, E. J. (1996) · BioEssays · doi:10.1002/bies.950180507 · Cited by 307 · see citing works
Drouin, J., Trifiro, M. A., Plante, R. K., Nemer, M., Eriksson, P., & Wrange, Ö. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5305-5314.1989 · Cited by 283 · see citing works
Tan, J.-A., JOSEPH, D. R., Quarmby, V. E., Lubahn, D. B., Sar, M., French, F. S., & Wilson, E. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1276 · Cited by 275 · see citing works
Nakajima, T., Uchida, C., Anderson, S. F., Parvin, J. D., & Montminy, M. (1997) · Genes & Development · doi:10.1101/gad.11.6.738 · Cited by 238 · see citing works
Mutual Transcriptional Interference between RelA and Androgen Receptor
Palvimo, J. J., Reinikainen, P., Ikonen, T., Kallio, P. J., Moilanen, A., & Jänne, O. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24151 · Cited by 212 · see citing works
Self-citationOelgeschläger, M., Janknecht, R., Krieg, J., Schreek, S., & Lüscher, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00637.x · Cited by 210 · see citing works
Adaptor-mediated Recruitment of RNA Polymerase II to a Signal-dependent Activator
Kee, B. L., Arias, J., & Montminy, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2373 · Cited by 203 · see citing works
Sato, N., Sadar, M. D., Bruchovsky, N., Saatcioglu, F., Rennie, P. S., Sato, S., Lange, P. H., & Gleave, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17485 · Cited by 202 · see citing works
MAP Kinase-Dependent Transcriptional Coactivation by Elk-1 and Its Cofactor CBP
Janknecht, R., & Nordheim, A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1740 · Cited by 191 · see citing works
Shemshedini, L., Knauthe, R., Sassone‐Corsi, P., Pornon, A., & Gronemeyer, H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04953.x · Cited by 188 · see citing works
Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation
Ikonen, T., Palvimo, J. J., Kallio, P. J., Reinikainen, P., & Jänne, O. A. (1994) · Endocrinology · doi:10.1210/endo.135.4.7925097 · Cited by 187 · see citing works
Self-citationMcEwan, I., & Gustafsson, J.-Å. (1997) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.94.16.8485 · Cited by 186 · see citing works
Mechanism of gene expression by the glucocorticoid receptor: Role of protein‐protein interactions
McEwan, I. J., Wright, A. P. H., & Gustafsson, J.-Α. (1997) · BioEssays · doi:10.1002/bies.950190210 · Cited by 179 · see citing works
SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein.Preprint
Oliner, J., Andresen, J. M., Hansen, S. K., Zhou, S., & Tjian, R. (1996) · Genes & Development · doi:10.1101/gad.10.22.2903 · Cited by 158 · see citing works
Transcriptional Activators Differ in Their Responses to Overexpression of TATA-Box-Binding Protein
Sadovsky, Y., Webb, P., Lopez, G. N., Baxter, J. D., Fitzpatrick, P. M., Gizang-Ginsberg, E., Cavaillès, V., Parker, M. G., & Kushner, P. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1554 · Cited by 157 · see citing works
Kallio, P. J., Poukka, H., Moilanen, A., Jänne, O. A., & Palvimo, J. J. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.8.7476976 · Cited by 139 · see citing works
Self-citationRegulation of the c-fos promoter by the ternary complex factor Sap-1a and its coactivator CBP.
Janknecht, R., & Nordheim, A. (1996) · PubMed · Cited by 120 · see citing works
c-Jun Can Mediate Androgen Receptor-induced Transactivation
Bubulya, A., Wise, S., Shen, X.-Q., Burmeister, L. A., & Shemshedini, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24583 · Cited by 110 · see citing works
Palvimo, J. J., Kallio, P. J., Ikonen, T., Mehto, M., & Jänne, O. A. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.11.8114755 · Cited by 92 · see citing works
Self-citationEffects of mitogens on androgen receptor-mediated transactivation
Reinikainen, P., Palvimo, J. J., & Jänne, O. A. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828495 · Cited by 85 · see citing works
Self-citationHeckert, L. L., Wilson, E. M., & Nilson, J. H. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.10.9996 · Cited by 57 · see citing works
Cairns, C. A., Cairns, W. J., & Okret, S. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.695 · Cited by 55 · see citing works
Proteins with transcription regulatory properties encoded by human adenoviruses
Akusjärvi, G. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90085-6 · Cited by 40 · see citing works
Characterization of cell-specific modulatory element in the murine ornithine decarboxylase promoter
Palvimo, J. J., Partanen, M., & Jänne, O. A. (1996) · Biochemical Journal · doi:10.1042/bj3160993 · Cited by 25 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- [4]Ing N H, Beekman J M, Tsai S Y, Tsai M-J, O’Malley B W. J Biol Chem. 1992;267:17617–17623. [PubMed] [Google Scholar]
- [14]Bannister A J, Oehler T, Wilhelm D, Angel P, Kouzarides T. Oncogene. 1995;11:2509–2514. [PubMed] [Google Scholar]
- [18]Oelgeschläger M, Janknecht R, Krieg J, Schreek S, Lüscher B. EMBO J. 1996;15:2771–2780. [PMC free article] [PubMed] [Google Scholar]
- [19]Janknecht R, Nordheim A. Oncogene. 1996;12:1961–1969. [PubMed] [Google Scholar]
- [41]Voegel J J, Heine M J S, Zechel C, Chambon P, Gronemeyer H. EMBO J. 1996;15:3667–3675. [PMC free article] [PubMed] [Google Scholar]
Cited by
Sorted by citations
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,079 · see citing works
Steffan, J. S., Kazantsev, A. G., Spasić-Bošković, O., Greenwald, M., Zhu, Y., Goehler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,057 · see citing works
Molecular Biology of the Androgen Receptor
Gelmann, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.018 · Cited by 944 · see citing works
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943 · see citing works
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · see citing works
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753 · see citing works
CREB-binding protein sequestration by expanded polyglutamine
McCampbell, A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.14.2197 · Cited by 547 · see citing works
Andersen, R. J., Mawji, N. R., Wang, J., Wang, G., Haile, S., Myung, J.-K., Watt, K., Tam, T., Yang, Y. C., Bañuelos, C. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.027 · Cited by 503 · see citing works
Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., Ogryzko, V. V., Avantaggiati, M. L., & Pestell, R. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000660200 · Cited by 409 · see citing works
FHL2, a novel tissue‐specific coactivator of the androgen receptor
Müller, J. M., Isele, U., Metzger, E., Rempel, A., Moser, M., Pscherer, A., Breyer, T., Holubarsch, C., Buettner, R., & Schüle, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.359 · Cited by 326 · see citing works
An androgen receptor N-terminal domain antagonist for treating prostate cancer
Myung, J., Banuelos, C. A., Fernandez, J. G., Mawji, N. R., Wang, J., Tien, A. H., Yang, Y. C., Tavakoli, I., Haile, S., Watt, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66398 · Cited by 307 · see citing works
Targeting the p300/CBP Axis in Lethal Prostate Cancer
Welti, J. C., Sharp, A., Brooks, N. A. N., Yuan, W., McNair, C. M., Chand, S. N., Pal, A., Figueiredo, I., Riisnaes, R., Gürel, B., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0751 · Cited by 286 · see citing works
Gao, N., Zhang, J., Rao, M. A., Case, T. C., Mirosevich, J., Wang, Y., Jin, R., Gupta, A., Rennie, P. S., & Matusik, R. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0020 · Cited by 279 · see citing works
Oettgen, P., Finger, E., Sun, Z., Akbarali, Y., Thamrongsak, U., Boltax, J., Grall, F., Dube, A., Weiss, A., Brown, L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1216 · Cited by 268 · see citing works
Alen, P., Claessens, F., Verhoeven, G., Rombauts, W., & Peeters, B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6085 · Cited by 268 · see citing works
The Androgen Receptor in Health and Disease
Μatsumoto, T., Sakari, M., Okada, M., Yokoyama, A., Takahashi, S., Kouzmenko, A., & Kato, S. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183656 · Cited by 268 · see citing works
Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
Irvine, R. A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.267 · Cited by 263 · see citing works
De Bosscher, K. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00297-6 · Cited by 264 · see citing works
Wnt signaling in triple negative breast cancer is associated with metastasis
Dey, N., Barwick, B. G., Moreno, C. S., Ordanic-Kodani, M., Chen, Z., Oprea-Ilies, G. M., Tang, W., Catzavelos, C., Kerstann, K. F., Sledge, G. W., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-537 · Cited by 256 · see citing works
Chmelar, R. S., Buchanan, G., Need, E. F., Tilley, W. D., & Greenberg, N. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22365 · Cited by 256 · see citing works
Cross-talk between nuclear receptors and nuclear factor κB
Bosscher, K. D., Berghe, W. V., & Haegeman, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209935 · Cited by 247 · see citing works
Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids
Almawi, W., & Melemedjian, O. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280069 · Cited by 242 · see citing works
Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
Bartsch, G., Rittmaster, R. S., & Klocker, H. (2000) · European Urology · doi:10.1159/000020181 · Cited by 240 · see citing works
Sex hormones and their receptors regulate liver energy homeostasis
Shen, M., & Shi, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/294278 · Cited by 239 · see citing works
Histone deacetylase inhibitors reduce polyglutamine toxicity
McCampbell, A., Taye, A. A., Whitty, L., Penney, E. B., Steffan, J. S., & Fischbeck, K. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261400698 · Cited by 239 · see citing works
Cross-talk between glucocorticoid receptor and AP-1
Herrlich, P. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204388 · Cited by 229 · see citing works
Lavery, D. N., & Mcewan, I. J. (2005) · Biochemical Journal · doi:10.1042/bj20050872 · Cited by 227 · see citing works
Moilanen, A., Poukka, H., Karvonen, U., Häkli, M., Jänne, O. A., & Palvimo, J. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5128 · Cited by 209 · see citing works
Self-citationDiversity in the mechanisms of gene regulation by estrogen receptors
Sánchez, R., Nguyen, D., Rocha, W., White, J. H., & Mader, S. (2002) · BioEssays · doi:10.1002/bies.10066 · Cited by 200 · see citing works
Gelman, L., Fruchart, J., & Auwerx, J. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050345 · Cited by 219 · see citing works
Almawi, W. Y., & Melemedjian, O. K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.9 · Cited by 196 · see citing works
Androgen-Insensitivity Syndrome as a Possible Coactivator Disease
Adachi, M., Takayanagi, R., Tomura, A., Imasaki, K., Kato, S., Goto, K., Yanase, T., Ikuyama, S., & Nawata, H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431205 · Cited by 192 · see citing works
Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer
Gnanapragasam, V. J., Leung, H. Y., Pulimood, A., Neal, D. E., & Robson, C. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2179 · Cited by 189 · see citing works
Li, Q., Herrler, M., Landsberger, N., Kaludov, N. K., Ogryzko, V. V., Nakatani, Y., & Wolffe, A. P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6300 · Cited by 184 · see citing works
Acetylation of nuclear receptors in cellular growth and apoptosis
Fu, M., Wang, C., Zhang, X., & Pestell, R. G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.037 · Cited by 183 · see citing works
Topper, J. N., DiChiara, M. R., Brown, J. D., Williams, A. J., Falb, D., Collins, T., & Gimbrone, M. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9506 · Cited by 180 · see citing works
Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription
Poukka, H., Aarnisalo, P., Karvonen, U., Palvimo, J. J., & Jänne, O. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19441 · Cited by 174 · see citing works
Self-citationAberrant HOXC expression accompanies the malignant phenotype in human prostate.
Miller, G. J., Miller, H. L., van Bokhoven, A., Lambert, J. R., Werahera, P. N., Schirripa, O., Lucia, M. S., & Nordeen, S. K. (2003) · PubMed · Cited by 171 · see citing works
Fu, M., Wang, C., Wang, J., Zhang, X., Sakamaki, T., Yeung, Y. G., Chang, C., Hopp, T., Fuqua, S. A. W., Jaffray, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3373-3388.2002 · Cited by 170 · see citing works
Self-citationSong, L.-N., Herrell, R., Byers, S., Shah, S., Wilson, E. M., & Gelmann, E. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1674-1687.2003 · Cited by 169 · see citing works
Androgen receptor signaling and mutations in prostate cancer
Koochekpour, S. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.89 · Cited by 167 · see citing works
Narayanan, B. A., Narayanan, N. K., Re, G. G., & Nixon, D. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.10932 · Cited by 164 · see citing works
Recent advances in androgen receptor action
Lee, H.-J., & Chang, C. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2309-3 · Cited by 162 · see citing works
Li, P., Lee, H., Guo, S., Unterman, T. G., Jenster, G. W., & Bai, W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.104-118.2003 · Cited by 160 · see citing works
McEwan, I. J. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110281 · Cited by 156 · see citing works
Svensson, C., Ceder, J. A., Iglesias‐Gato, D., Chuan, Y.-C., Pang, S., Bjartell, A. S., Merino-Martinez, R., Bott, L., Helczynski, L., Ulmert, D., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt921 · Cited by 154 · see citing works
Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor
Chesire, D. R., & Isaacs, W. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206049 · Cited by 151 · see citing works
Ras signaling in prostate cancer progression
Weber, M. J., & Gioeli, D. G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10683 · Cited by 148 · see citing works
Prostate cancer: molecular biology of early progression to androgen independence.
Sadar, M. D., Hussain, M., & Bruchovsky, N. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060487 · Cited by 148 · see citing works
Fontes, J. D., Kanazawa, S., Jean, D., & Peterlin, B. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.941 · Cited by 146 · see citing works
Inhibition of Androgen Receptor (AR) Function by the Reproductive Orphan Nuclear Receptor DAX-1
Holter, E., Kotaja, N., Mäkelä, S., Strauss, L., Kietz, S., Jänne, O. A., Gustafsson, J.-Α., Palvimo, J. J., & Treuter, E. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0804 · Cited by 144 · see citing works
Self-citationDeterminants of Receptor- and Tissue-Specific Actions in Androgen Signaling
Pihlajamaa, P., Sahu, B., & Jänne, O. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1034 · Cited by 141 · see citing works
Self-citationExpression of Androgen Receptor Coregulators in Prostate Cancer
Linja, M. J., Porkka, K. P., Kang, Z., Savinainen, K., Jänne, O. A., Tammela, T. L. J., Vessella, R. L., Palvimo, J. J., & Visakorpi, T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0990-3 · Cited by 140 · see citing works
Self-citationAndrogen receptor phosphorylation: biological context and functional consequences
Koryakina, Y. A., Ta, H. Q., & Gioeli, D. G. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0472 · Cited by 136 · see citing works
Heterogeneous Expression and Functions of Androgen Receptor Co-Factors in Primary Prostate Cancer
Li, P., Yu, X., Ge, K., Melamed, J., Roeder, R. G., & Wang, Z. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64422-7 · Cited by 136 · see citing works
Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice
Abel, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.107 · Cited by 135 · see citing works
Androgen effects on bone metabolism: recent progress and controversies
Hofbauer, L. C., & Khosla, S. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400271 · Cited by 135 · see citing works
Breast cancer: from estrogen to androgen receptor
Andò, S., Amicis, F. D., Rago, V., Carpino, A., Maggiolini, M., Panno, M., & Lanzino, M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00105-3 · Cited by 130 · see citing works
p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6
Gingras, S., Simard, J., Groner, B., & Pfitzner, E. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.13.2722 · Cited by 129 · see citing works
Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
Bartsch, G., Rittmaster, R., & Klocker, H. (2002) · World Journal of Urology · doi:10.1007/s00345-002-0248-5 · Cited by 128 · see citing works
Hypoxia in prostate cancer: A powerful shield against tumour destruction?
Marignol, L. H., Coffey, M. A., Lawler, M., & Hollywood, D. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.006 · Cited by 123 · see citing works
Androgen receptor coregulators: recruitment via the coactivator binding groove
van de Wijngaart, D. J., Dubbink, H. J., van Royen, M. E., Trapman, J., & Jenster, G. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.007 · Cited by 122 · see citing works
Signal transduction in prostate cancer progression
Gioeli, D. G. (2005) · Clinical Science · doi:10.1042/cs20040329 · Cited by 116 · see citing works
Beta-catenin signaling in prostate cancer: an early perspective.
Chesire, D. R., & Isaacs, W. B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100537 · Cited by 115 · see citing works
Zhou, X., Shen, X.-Q., & Shemshedini, L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0237 · Cited by 114 · see citing works
Waddell, A. R., Huang, H., & Liao, D. (2021) · Cancers · doi:10.3390/cancers13122872 · Cited by 110 · see citing works
Sone, K., Hinago, M., Itamoto, M., Katsu, Y., Watanabe, H., Urushitani, H., Tooi, O., Guillette, L. J., & Iguchi, T. (2005) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2005.03.007 · Cited by 110 · see citing works
Berghe, W. V., Francesconi, E., Bosscher, K. D., Resche-Rigon, M., & Haegeman, G. (1999) · PubMed · Cited by 108 · see citing works
Discovery of Chemical Inhibitors of Human Bromodomains
Zhang, G., Smith, S. G., & Zhou, M. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00205 · Cited by 107 · see citing works
Androgen signaling and its interactions with other signaling pathways in prostate cancer
Kaarbø, M., Klokk, T. I., & Saatcioglu, F. (2007) · BioEssays · doi:10.1002/bies.20676 · Cited by 106 · see citing works
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
Jung, C., Kim, R.-S., Zhang, H., Lee, S., Sheng, H., Loehrer, P. J., Gardner, T. A., Jeng, M. H., & Kao, C. H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602631 · Cited by 104 · see citing works
A Coregulatory Role for the TRAP-Mediator Complex in Androgen Receptor-mediated Gene Expression
Wang, Q., Sharma, D., Ren, Y., & Fondell, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206061200 · Cited by 104 · see citing works
Inhibition of Androgen Receptor-Mediated Transcription by Amino-Terminal Enhancer of split
Yu, X., Li, P., Roeder, R. G., & Wang, Z. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4614-4625.2001 · Cited by 104 · see citing works
A Tissue-Specific Enhancer of the Prostate-Specific Membrane Antigen Gene, FOLH1
Watt, F., Martorana, A., Brookes, D., Ho, T., Kingsley, E. A., O’Keefe, D. S., Russell, P. J., Heston, W. D. W., & Molloy, P. L. (2001) · Genomics · doi:10.1006/geno.2000.6446 · Cited by 103 · see citing works
Shenk, J. L., Fisher, C. J., Chen, S., Zhou, X., Tillman, K. C., & Shemshedini, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103652200 · Cited by 103 · see citing works
Valentine, J. E., Kalkhoven, E., White, R., Hoare, S., & Parker, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002497200 · Cited by 102 · see citing works
Glucocorticoid Repression of AP-1 Is Not Mediated by Competition for Nuclear Coactivators
Bosscher, K. D., Berghe, W. V., & Haegeman, G. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.2.0591 · Cited by 95 · see citing works
Debes, J. D., Comuzzi, B., Schmidt, L. J., Dehm, S. M., Culig, Z., & Tindall, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2837 · Cited by 92 · see citing works
Chang, C., Yeh, S., Lee, S. O., & Chang, T. (2013) · Nuclear Receptor Signaling · doi:10.1621/nrs.11001 · Cited by 91 · see citing works
Hosohata, K., Li, P., Hosohata, Y., Qin, J., Roeder, R. G., & Wang, Z. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.7019-7029.2003 · Cited by 91 · see citing works
Regulation of vertebrate corticotropin-releasing factor genes
Yao, M., & Denver, R. J. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.01.046 · Cited by 87 · see citing works
Mayeur, G. L., Kung, W.-J., Martinez, A. D., Izumiya, C., Chen, D. J., & Kung, H.-J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413336200 · Cited by 86 · see citing works
Yang, Z., Chang, Y., Miyamoto, H., Ni, J., Niu, Y., Chen, Z.-D., Chen, Y., Yao, J. L., di Sant'Agnese, P. A., & Chang, C. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0104 · Cited by 83 · see citing works
Blankvoort, B. M. G., de Groene, E. M., Kreikamp, A. P., Witkamp, R. F., Rodenburg, R. J., & Aarts, J. M. M. J. G. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5352 · Cited by 80 · see citing works
Malinen, M., Niskanen, E. A., Kaikkonen, M. U., & Palvimo, J. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw855 · Cited by 80 · see citing works
Self-citationEpigenetic Mechanisms for Progression of Prostate Cancer
Rennie, P. S., & Nelson, C. C. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006121219097 · Cited by 80 · see citing works
Li, Q., Imhof, A., Collingwood, T. N., Urnov, F. D., & Wolffe, A. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5634 · Cited by 78 · see citing works
Morimoto, S., Fernández‐Mejía, C., Romero-Navarro, G., Morales-Peza, N., & Díaz‐Sánchez, V. (2001) · Endocrinology · doi:10.1210/endo.142.4.8069 · Cited by 78 · see citing works
Chen, S.-Y., Cai, C., Fisher, C. J., Zheng, Z., Omwancha, J., Hsieh, C.-L., & Shemshedini, L. (2006) · Oncogene · doi:10.1038/sj.onc.1209705 · Cited by 77 · see citing works
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
Boorjian, S. A., Heemers, H. V., Frank, I., Farmer, S. A., Schmidt, L. J., Sebo, T. J., & Tindall, D. J. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0124 · Cited by 76 · see citing works
Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1
Zhang, Y., Fondell, J. D., Wang, Q., Xia, X., Cheng, A., Lu, M. L., & Hamburger, A. W. (2002) · Oncogene · doi:10.1038/sj.onc.1205638 · Cited by 76 · see citing works
Yeh, S., Kang, H., Miyamoto, H., Nishimura, K., Chang, H., Ting, H., Rahman, M. M., Lin, H., Fujimoto, N., Hu, Y., et al. (1999) · Endocrine · doi:10.1385/endo:11:2:195 · Cited by 77 · see citing works
Thiruppathi, M., Palaniappan, M., & Balasubramanian, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.010 · Cited by 77 · see citing works
Comuzzi, B., Lambrinidis, L., Rogatsch, H., Godoy‐Tundidor, S., Knežević, N., Krhen, I., Mareković, Z., Bartsch, G. H., Klocker, H., Hobisch, A., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63814-x · Cited by 76 · see citing works
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
Rau, K.-M., Kang, H.-Y., Cha, T.-L., Miller, S. A., & Hung, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01026 · Cited by 76 · see citing works
Poukka, H., Aarnisalo, P., Santti, H., Jänne, O. A., & Palvimo, J. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.571 · Cited by 74 · see citing works
Self-citationVerhovshek, T., Cai, Y., Osborne, M. C., & Sengelaub, D. R. (2009) · Endocrinology · doi:10.1210/en.2009-1036 · Cited by 73 · see citing works
Saitoh, M., Takayanagi, R., Goto, K., Fukamizu, A., Tomura, A., Yanase, T., & Nawata, H. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.694 · Cited by 73 · see citing works
Matsuda, T., Junicho, A., Yamamoto, T., Kishi, H., Korkmaz, K., Saatcioglu, F., Fuse, H., & Muraguchi, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4758 · Cited by 73 · see citing works
The androgen receptor: a potential target for therapy of prostate cancer
dos Santos, A. F., Huang, H., & Tindall, D. J. (2003) · Steroids · doi:10.1016/j.steroids.2003.10.005 · Cited by 73 · see citing works
- Authors
- Aarnisalo, P., Palvimo, J. J., & Jänne, O. A.
- Affiliations
- University of Helsinki (FI)
- ORCID
- Palvimo, Jorma J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-03-03
- Volume
- 95
- Issue
- 5
- Pages
- 2122-2127
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19270
- OpenAlex
- W2023929246
- Cited by
- 255
- References
- 56
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 8 · 2014: 3 · 2013: 9 · 2012: 6
- FWCI
- 23.10
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- CREB-binding protein, androgen receptor, transcriptional coactivator, AP-1, NF-κB, RelA, transcriptional repression, transcriptional interference, E1A protein, ligand-binding domain, protein-protein interaction, signaling pathway integration
- MeSH terms
- Animals, Binding Sites, Cell Line, Humans, Kinetics, Nuclear Proteins, Receptors, Androgen, Receptors, Glucocorticoid, Transcription Factors, Transcription, Genetic, Transfection, Protein Engineering, Signal Transduction, Transcriptional Activation, Trans-Activators, Sequence Deletion, Transcription Factor AP-1, COS Cells, CREB-Binding Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review